UBS Group’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $854K | Buy |
231,345
+229,915
| +16,078% | +$859K | ﹤0.01% | 5669 |
|
|
2025
Q4 | $5K | Sell |
1,430
-11,286
| -89% | -$39.4K | ﹤0.01% | 8740 |
|
|
2025
Q3 | $27.2K | Buy |
12,716
+12,311
| +3,040% | +$26.1K | ﹤0.01% | 7964 |
|
|
2025
Q2 | $911 | Sell |
405
-3,903
| -91% | -$5.5K | ﹤0.01% | 9711 |
|
|
2025
Q1 | $5.9K | Buy |
4,308
+457
| +12% | +$630 | ﹤0.01% | 8950 |
|
|
2024
Q4 | $6.08K | Buy |
3,851
+3,146
| +446% | +$4.4K | ﹤0.01% | 8597 |
|
|
2024
Q3 | $874 | Sell |
705
-568
| -45% | -$717 | ﹤0.01% | 8790 |
|
|
2024
Q2 | $1.71K | Buy |
1,273
+769
| +153% | +$1.13K | ﹤0.01% | 8516 |
|
|
2024
Q1 | $685 | Sell |
504
-3,776
| -88% | -$8.03K | ﹤0.01% | 8414 |
|
|
2023
Q4 | $11.2K | Buy |
4,280
+3,880
| +970% | +$9.39K | ﹤0.01% | 7403 |
|
|
2023
Q3 | $1.28K | Hold |
400
| – | – | ﹤0.01% | 8004 |
|
|
2023
Q2 | $2.01K | Sell |
400
-182
| -31% | -$922 | ﹤0.01% | 7819 |
|
|
2023
Q1 | $1.68K | Sell |
582
-35
| -6% | -$102 | ﹤0.01% | 8676 |
|
|
2022
Q4 | $1.44K | Sell |
617
-888,427
| -100% | -$2.71M | ﹤0.01% | 9865 |
|
|
2022
Q3 | $3.99M | Buy |
889,044
+7,432
| +0.8% | +$53.2K | ﹤0.01% | 2560 |
|
|
2022
Q2 | $5.17M | Buy |
+881,612
| New | +$4.52M | ﹤0.01% | 2351 |
|
|
2022
Q1 | – | Sell |
-3,000
| Closed | -$38K | – | 10210 |
|
|
2021
Q4 | $38K | Hold |
3,000
| – | – | ﹤0.01% | 7169 |
|
|
2021
Q3 | $42K | Hold |
3,000
| – | – | ﹤0.01% | 6474 |
|
|
2021
Q2 | $31K | Hold |
3,000
| – | – | ﹤0.01% | 6874 |
|
|
2021
Q1 | $29K | Hold |
3,000
| – | – | ﹤0.01% | 7034 |
|
|
2020
Q4 | $22K | Sell |
3,000
-2,000
| -40% | -$13.3K | ﹤0.01% | 6863 |
|
|
2020
Q3 | $24K | Sell |
5,000
-1,000
| -17% | -$4.95K | ﹤0.01% | 6151 |
|
|
2020
Q2 | $33K | Hold |
6,000
| – | – | ﹤0.01% | 6200 |
|
|
2020
Q1 | $22K | Sell |
6,000
-4,000
| -40% | -$26.8K | ﹤0.01% | 6428 |
|
|
2019
Q4 | $85K | Buy |
10,000
+4,000
| +67% | +$28.9K | ﹤0.01% | 6081 |
|
|
2019
Q3 | $41K | Sell |
6,000
-2,000
| -25% | -$14.2K | ﹤0.01% | 6301 |
|
|
2019
Q2 | $54K | Hold |
8,000
| – | – | ﹤0.01% | 5848 |
|
|
2019
Q1 | $50K | Sell |
8,000
-2,721
| -25% | -$21.1K | ﹤0.01% | 5544 |
|
|
2018
Q4 | $70K | Buy |
10,721
+5,603
| +109% | +$33.9K | ﹤0.01% | 5831 |
|
|
2018
Q3 | $36K | Buy |
5,118
+1,118
| +28% | +$6.21K | ﹤0.01% | 6410 |
|
|
2018
Q2 | $17K | Sell |
4,000
-284
| -7% | -$1.05K | ﹤0.01% | 6802 |
|
|
2018
Q1 | $13K | Sell |
4,284
-3,807
| -47% | -$9.8K | ﹤0.01% | 6701 |
|
|
2017
Q4 | $21K | Buy |
8,091
+1,320
| +19% | +$4.12K | ﹤0.01% | 6507 |
|
|
2017
Q3 | $23K | Sell |
6,771
-5,050
| -43% | -$13K | ﹤0.01% | 6340 |
|
|
2017
Q2 | $30K | Buy |
11,821
+3,402
| +40% | +$8.36K | ﹤0.01% | 6011 |
|
|
2017
Q1 | $23K | Buy |
8,419
+1,295
| +18% | +$4.3K | ﹤0.01% | 6033 |
|
|
2016
Q4 | $25K | Buy |
7,124
+4,124
| +137% | +$18.4K | ﹤0.01% | 6369 |
|
|
2016
Q3 | $16K | Sell |
3,000
-8,264
| -73% | -$26.8K | ﹤0.01% | 6464 |
|
|
2016
Q2 | $18K | Sell |
11,264
-1,341
| -11% | -$2.33K | ﹤0.01% | 6377 |
|
|
2016
Q1 | $21K | Buy |
12,605
+9,525
| +309% | +$19.2K | ﹤0.01% | 6162 |
|
|
2015
Q4 | $6K | Sell |
3,080
-2,768
| -47% | -$5.35K | ﹤0.01% | 7588 |
|
|
2015
Q3 | $11K | Buy |
5,848
+1,180
| +25% | +$2.71K | ﹤0.01% | 7189 |
|
|
2015
Q2 | $13K | Sell |
4,668
-3,432
| -42% | -$9.45K | ﹤0.01% | 7244 |
|
|
2015
Q1 | $19K | Buy |
8,100
+5,100
| +170% | +$17K | ﹤0.01% | 7020 |
|
|
2014
Q4 | $11K | Buy |
+3,000
| New | +$11.7K | ﹤0.01% | 8289 |
|
Other funds holding APYX
NCM
ACM
RA
VCM
ACM
SBCM
EIM
HKAM
